C-Raf

From Wikipedia, the free encyclopedia

The correct title of this article is c-Raf. The initial letter is shown capitalized due to technical restrictions.
v-raf-1 murine leukemia viral oncogene homolog 1
Identifiers
Symbol(s) RAF1
Entrez 5894
OMIM 164760

c-raf is gene that codes for a protein kinase. That protein is sometimes called c-Raf and will be called "Raf-1" here. The Raf-1 protein functions in the MAPK/ERK signal transduction pathway as part of a protein kinase cascade. Raf-1 is a serine/threonine-specific kinase (EC 2.7.11.1).

Contents

Diagramatic representation of how Raf-1 (RAF) might shift between active and inactive conformations and control activation of MEK. In this diagram, "P" represents phosphate, "259" indicates serine-259 in the Raf-1 structure and AKT is a protein kinase that can phosphorylate serine-259 of Raf-1.  EGF is a growth factor that activates RAS, and PP1 is a phosphatase that has been shown to dephosphorylate serine-259 of Raf-1. Additional details are given in the main text of this article.
Diagramatic representation of how Raf-1 (RAF) might shift between active and inactive conformations and control activation of MEK. In this diagram, "P" represents phosphate, "259" indicates serine-259 in the Raf-1 structure and AKT is a protein kinase that can phosphorylate serine-259 of Raf-1. EGF is a growth factor that activates RAS, and PP1 is a phosphatase that has been shown to dephosphorylate serine-259 of Raf-1. Additional details are given in the main text of this article.

The first raf gene that was found was the oncogene v-raf.[1] Normal (non-oncogenic) cellular homologs of v-raf were soon found to be conserved components of eukaryotic genomes and it was shown that they could mutate and become oncogenes.[2] A-Raf (Mendelian Inheritance in Man (OMIM) 311010) and Raf-B (Mendelian Inheritance in Man (OMIM) 164757) are two protein kinases with similar sequences to Raf-1. Mutations in B-Raf genes are found in several types of cancer. The Raf kinases are targets for anticancer drug development.[3]

Raf-1 was shown to bind efficiently to Ras only when Ras is bound to GTP, not GDP.[4] In the MAPK/ERK pathway Raf-1 becomes activated when it binds to Ras.[5] It is thought that phosphorylation of Raf-1 (at sites such as serine-338) upon binding of Raf-1 to Ras locks Raf-1 into an activated conformation that is then independent of binding to Ras for the continued activity of Raf-1.[6] Several MAPK kinase kinase kinases have been suggested to be important for phosphorylation of Raf-1 as well as positive feedback phosphorylation by MAPK (ERK).[7]

Binding of 14-3-3ζ to phosphorylated serine-259 of Raf-1 is associated with inhibition of Raf-1 kinase activity. As shown in the figure (to the right), it is thought that a 14-3-3 dimer can bind to two phosphoserines of Raf-1 when it is inactive. Dephosphorylation of serine-259 has been associated with activation of Raf-1.[8] In the model shown, the binding of GTP to Ras and the dephosphorylation of serine-259 of Raf-1 allows Raf-1 to take on a conformation that allows binding of Raf-1 to Ras-GTP. This represents a conformation in which Raf-1 can phosphorylate the downstream target MEK.

In the MAPK/ERK pathway Raf-1 phosphorylates and activates MEK, a MAPK kinase.[9] This allows Raf-1 to function as part of a kinase cascade: Raf-1 phosphorylates MEK which phosphorylates MAPK (see MAPK/ERK pathway).

  1. ^ G. E. Mark and U. R. Rapp (1984) "Primary structure of v-raf: relatedness to the src family of oncogenes" in Science Volume 224, pages 285-289. Entrez PubMed 6324342
  2. ^ K. Shimizu, Y. Nakatsu, S. Nomoto and M. Sekiguchi. (1986) "Structure of the activated c-raf-1 gene from human stomach cancer" in Int. Symp. Princess Takamatsu Cancer Res. Fund Volume 17, pages 85-91. Entrez PubMed 2843497
  3. ^ S. S. Sridhar, D. Hedley and L. L. Siu (2005) "Raf kinase as a target for anticancer therapeutics" in Molecular cancer therapeutics Volume 4, pages 677-685. Entrez PubMed 15827342
  4. ^ X. F. Zhang, J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp and J. Avruch (1993) "Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1" in Nature Volume 364, pages 308-313.Entrez PubMed 8332187
  5. ^ K. Terai and M. Matsuda (2005) "Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase" in EMBO reports Volume 6, page 251-255. Entrez PubMed 15711535
  6. ^ J. Avruch, A. Khokhlatchev, J. M. Kyriakis, Z. Luo, G. Tzivion, D. Vavvas X. F. Zhang (2001) "Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade" in Recent Progress in Hormone Research Volume 56, pages 127-155.Entrez PubMed 11237210
  7. ^ V. Balan, D. T. Leicht, J. Zhu, K. Balan, A. Kaplun, V. Singh-Gupta, J. Qin, H. Ruan, M. J. Comb and G. Tzivion (2006) "Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase" in Molecular biology of the cell Volume 17, pages 1141-1153. Entrez PubMed 16407412
  8. ^ P. Rodriguez-Viciana, J. Oses-Prieto, A. Burlingame, M. Fried and F. McCormick (2006) "A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity" Molecular Cell Volume 22, pages 217-230. Entrez PubMed 16630891
  9. ^ J. M. Kyriakis, H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp and J. Avruch (1992) "Raf-1 activates MAP kinase-kinase" in Nature Volume 358, pages 417-421.Entrez PubMed 1322500
Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.